Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 35Nasopharyngeal Carcinoma 19Oropharyngeal Neoplasms 17Carcinoma, Squamous Cell 15Rectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 11Esophageal Squamous Cell Carcinoma 11Mouth Neoplasms 8Esophageal Neoplasms 8Pancreatic Neoplasms 7Laryngeal Neoplasms 7Sarcoma 6Tongue Neoplasms 5Papillomavirus Infections 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Glioblastoma 5Brain Neoplasms 5Stomatitis 4Neoplasm Metastasis 4Nasopharyngeal Neoplasms 4Carcinoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Carcinoma, Anaplastic 3Lymphatic Metastasis 3Gliosarcoma 3Glioma 3

Interventions

Cisplatin 11Carboplatin 7Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5Gemcitabine 5Cetuximab 5Trastuzumab 4Specimen Handling 4Radiotherapy 4Paclitaxel 4Sorafenib 3Nivolumab 3N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 3Lapatinib 3Goserelin 3Doxorubicin 3Capecitabine 3Biopsy 3sacituzumab govitecan 2darolutamide 2bicalutamide 2Radiotherapy, Intensity-Modulated 2Platinum 2Oxaliplatin 2Leuprolide 2Irinotecan 2Ipilimumab 2Dasatinib 2Chemotherapy, Adjuvant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Salivary Gland Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT01220583 2026-05-27

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

Radiation Therapy Oncology Group

Phase 2 Active not recruiting
252 enrolled
Head & Neck

Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT05075980 2026-04-13

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

Mayo Clinic

Phase 2 Active not recruiting
174 enrolled
Head & Neck

Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphatic Metastasis, Mouth Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡